Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Rating) shares shot up 2.9% on Friday . The stock traded as high as $2.13 and last traded at $2.11. 11,274 shares traded hands during trading, a decline of 99% from the average session volume of 1,191,421 shares. The stock had previously closed at $2.05.
Wall Street Analysts Forecast Growth
Separately, StockNews.com raised shares of Amneal Pharmaceuticals from a “hold” rating to a “buy” rating in a research note on Friday, September 16th.
Amneal Pharmaceuticals Price Performance
The company has a current ratio of 1.56, a quick ratio of 1.03 and a debt-to-equity ratio of 15.38.
Amneal Pharmaceuticals Company Profile
Amneal Pharmaceuticals, Inc, together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories.
- Get a free copy of the StockNews.com research report on Amneal Pharmaceuticals (AMRX)
- Why Does Tesla Stock Remain Resilient?
- 2 Semiconductor Stocks To Watch For Reversals
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
- Is Costco’s Post-Earnings Price Weakness A Good Time To Buy?
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
Receive News & Ratings for Amneal Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amneal Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.